Transparency tools in gene patenting for informing policy and practice

Nat Biotechnol. 2013 Dec;31(12):1086-93. doi: 10.1038/nbt.2755.

Abstract

The Supreme Court's decision in Myriad highlights the need for tools enabling nuanced and precise analysis of gene patents at the global level.

Supplementary information: The online version of this article (doi:10.1038/nbt.2755) contains supplementary material, which is available to authorized users.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Disclosure / legislation & jurisprudence*
  • Genes / genetics*
  • Genetic Engineering / legislation & jurisprudence*
  • Patents as Topic / legislation & jurisprudence*
  • Public Policy / legislation & jurisprudence*
  • Supreme Court Decisions*
  • United States